How long does LL-37 take to work?
In the first week of LL-37, subtle. Mild flu-like symptoms in first few doses for some users. Around week 4, full cycle. Reassess infection markers. By week 8, off-cycle. Response varies between people, this is the commonly reported pattern, not a guarantee.
Week by week
- Week 1: Subtle. Mild flu-like symptoms in first few doses for some users.
- Week 4: Full cycle. Reassess infection markers.
- Week 8: Off-cycle.
References
- LL-37, the truncation product of cathelicidin, antimicrobial review — Wang G, Curr Top Med Chem, 2020
- Human antimicrobial/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an update — Svensson D et al., Inflammation Research, 2025
- Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis — Mankowska A et al., Archivum Immunologiae et Therapiae Experimentalis, 2025
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on LL-37
Last updated 2026-06-06.